Trustworthy Multimodal Clinical AI
I evaluate calibration, uncertainty, patient-level harm, and subgroup performance across imaging and high-acuity care data.
View direction →AI scientist · Biostatistician · Applied mathematician
I study when clinical AI can be trusted, where it fails, and how uncertainty should affect a decision.
My work combines biostatistics, causal inference, and mechanistic modeling across medical images, electronic health records, physiological data, and biological systems. I focus on patient-level reliability rather than average performance alone.

Research agenda
Across imaging, electronic health records, and biological systems, I ask three practical questions: Where does the model fail? What does the evidence support? How should uncertainty change the decision?
I evaluate calibration, uncertainty, patient-level harm, and subgroup performance across imaging and high-acuity care data.
View direction →I use causal models and interpretable outcome analysis to study treatment response, patient selection, and prediction failure.
View direction →I connect mechanistic simulation with machine learning, optimal transport, and probabilistic surrogates for biomedical systems.
View direction →Current research
At MIT Critical Data, I evaluate diagnostic-imaging model ensembles and link patient-level error patterns to ICU care phenotypes in MIMIC-CXR and MIMIC-IV.
At Duke, I lead the statistical analysis of an SEEG-derived focality score and examine when it may help predict seizure freedom after epilepsy surgery.
In an NIH-supported Duke–Weill Cornell collaboration, I connect mechanistic CMV models with machine learning and cross-species immune-cell alignment.
Selected publications
H. Latifizadeh, A. C. Pirkey, A. Gould, D. J. Klinke II
First-author open framework for ensemble causal discovery, bootstrap stability, and edge-level uncertainty.
D. J. Klinke II, A. Fernandez, W. Deng, A. Razazan, H. Latifizadeh, A. C. Pirkey
Nature Communications. Computational analysis of how oncogenic gene expression changes tumor and immune-cell relationships.
H. Latifizadeh et al.
Statistical lead for a Duke study of the 5-SENSE focality score and postoperative seizure freedom.
Academic trajectory
My training moved from nonlinear systems and numerical methods to causal network inference, computational biology, biostatistics, and patient-level model evaluation.
Research experienceEditorial leadership
I serve on boards for npj Digital Medicine, iScience, and the International Journal of Modeling, Simulation, and Scientific Computing. I have reviewed more than 50 manuscripts.
Collaboration & contact
I welcome discussions on clinical AI evaluation, biostatistics, causal inference, computational biology, and mechanism-informed modeling.
Get in touch